M. Wada et al., OCCURRENCE OF GRAVES-DISEASE DURING RETREATMENT WITH INTERFERON-ALPHA-2A FOR CHRONIC HEPATITIS-C, Internal medicine, 34(11), 1995, pp. 1097-1100
The present report describes a patient who developed Graves' disease 3
months after inception of retreatment with higher doses of interferon
-alpha 2a for chronic hepatitis C, although the initial 6-month treatm
ent caused no serious adverse reactions, Severe hyperthyroidism contin
ued despite discontinuation of interferon-alpha 2a, and the patient wa
s subsequently treated with I-131. This case suggests careful evaluati
on of the safety of retreatment to prevent manifestation of such a com
plication in the retreatment of chronic hepatitis C with interferon.